{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/312851856"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The Company has three complementary business units: Patient Testing, Biomarker Identification, and Genetic Assays and Platforms, which provide specialized diagnostic tests, contract research services for drug development, and equipment, reagents and other consumables for clinical and research applications in molecular testing and cytogenetics." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "businesswire.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/245163089"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/312851856"] } } }
